Since several products preventing RSV infection in risk groups are expected to be soon available, PROMISE is starting to prepare for their introduction. Identifying potential barriers to RSV immunisation is a key element. This is way, through project partner ReSViNET, we are asking parents of infants and young children, pregnant women and their partners and adults older than 60 years old about their level of awareness of RSV infection and their confidence and attitudes towards vaccines.
During the duration of the project we plan to conduct two surveys; the first one is already ongoing and you can participate by clicking the link below. A second survey will launch at the end of the project (end of 2023) in EU countries (including Belgium, Netherlands, UK, Germany, Italy, Spain, Finland, and France).
Why is this survey important?
RSV is one of the most common respiratory viruses, which causes every year seasonal epidemics worldwide. It is a very contagious virus. RSV usually causes mild, cold-like symptoms, but can progress to lower respiratory tract infections such as bronchiolitis and pneumonia. Infants, young children and adults over the age of 60 are most at risk for a more severe course of this infection. RSV is the primary cause of hospitalization in infants under 12 months. PROMISE aims to support the development and introduction of new vaccinations and therapies against this serious virus in young children and adults over 60 years of age.
We need your support and appreciate your feedback immensely. It will take about 10 minutes to complete our questionnaire. It is completely anonymous. Sharing this information and link with family and friends who are pregnant or planning to become pregnant, parents of infants and young children and adults over the age of 60 will help us gain valuable insights and pave the way for RSV prevention.
Please contact us if you have any questions or wish to receive information about future surveys.